InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-47.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Fitzpatrick Alexander A, Conseiller Juridique et Secrétaire. Insider active across 3 companies, notably Evofem Biosciences, Inc.. Cumulatively, 8 disclosures have been published. Split: 3 buys · 1 sell. Total volume traded: €154k. History available since 20 May 2021. The latest transaction was disclosed on 20 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Fitzpatrick Alexander A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
3,355 sharesCommon StockSEC:0001398595-26-000004:0
100,000 shares@ US$5.5878.3% of flowCommon StockSEC:0001415889-25-014186:0
40,000 shares@ US$3.62421.7% of flowCommon StockSEC:0001209191-23-051073:0
Canonical exit: 27 Dec 2023 (T+90)
300,000 shares0Common StockSEC:0001618835-22-000031:0
120,000 shares0Common StockSEC:0001618835-22-000006:0
25,000 shares@ US$0.38918.5% of flowCommon StockSEC:0001618835-21-000273:0
Canonical exit: 20 Mar 2022 (T+90)
10,000 shares@ US$1.02518.0% of flowCommon StockSEC:0001618835-21-000146:0
Canonical exit: 8 Sept 2021 (T+90)
42,120 shares@ US$0.8663.4% of flowCommon StockSEC:0001618835-21-000137:0
8 of 8 declarations
About Fitzpatrick Alexander A
Alexander A. Fitzpatrick serves as General Counsel and Secretary for Evofem Biosciences, Inc. In this role, he is responsible for the company's legal matters and compliance. His expertise in corporate law is essential to ensure good governance at Evofem.
